The invention relates to a novel diagnostic marker CT-proADM (C-terminal fragment of preproADM, SEQ ID No, 1) for diagnosing and/or stratifying the risk of diseases. Also disclosed is a method for diagnosing and/or stratifying the risk of diseases, particularly cardiovascular diseases, cardiac insufficiency, and infections and/or inflammations of the lungs and respiratory tract. In said method, the CT-proADM (SEQ ID No. 1) marker, or a partial peptide of fragment thereof, or said marker contained in a marker combination (panel, cluster) is determined in a patient who is to be examined. The invention further relates to a diagnostic apparatus as well as a kit for carrying out said method.
展开▼
机译:本发明涉及用于诊断和/或分层疾病风险的新型诊断标志物CT-proADM(preproADM的C-末端片段,SEQ ID No,1)。还公开了一种用于诊断和/或分层疾病,特别是心血管疾病,心脏功能不全以及肺和呼吸道的感染和/或炎症的风险的方法。在所述方法中,在待检查的患者中确定CT-proADM(SEQ ID No.1)标志物或其片段的部分肽,或包含在标志物组合(面板,簇)中的所述标志物。本发明还涉及用于执行所述方法的诊断设备以及套件。
展开▼